A Multicenter Randomized Double-Blind Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn s Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Crohn's Disease
  • Age: Between 18 Year(s) - 150 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Able to provide written informed consent
    2. Have Crohn’s disease (CD)for greater than or 3 months prior to randomization
    3. Have moderately to severely active CD at Screening
    4. Demonstrated inadequate resp

You may not be eligible for this study if the following are true:

    1. History of inadequate response (ie, primary non-response) to agents from more than 2 classes of biologics marketed for the treatment of CD
    2. Have ulcerative colitis, indeterminate colitis, microscopic colitis, ischemic colitis, ra

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.